Strokelore: Antithrombotic therapy and hemorrhagic infarction.
Publication
, Journal Article
Powers, WJ
Published in: J Stroke Cerebrovasc Dis
April 2022
Duke Scholars
Published In
J Stroke Cerebrovasc Dis
DOI
EISSN
1532-8511
Publication Date
April 2022
Volume
31
Issue
4
Start / End Page
106395
Location
United States
Related Subject Headings
- Stroke
- Platelet Aggregation Inhibitors
- Neurology & Neurosurgery
- Infarction
- Humans
- Fibrinolytic Agents
- Brain Ischemia
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Powers, W. J. (2022). Strokelore: Antithrombotic therapy and hemorrhagic infarction. J Stroke Cerebrovasc Dis, 31(4), 106395. https://doi.org/10.1016/j.jstrokecerebrovasdis.2022.106395
Powers, William J. “Strokelore: Antithrombotic therapy and hemorrhagic infarction.” J Stroke Cerebrovasc Dis 31, no. 4 (April 2022): 106395. https://doi.org/10.1016/j.jstrokecerebrovasdis.2022.106395.
Powers WJ. Strokelore: Antithrombotic therapy and hemorrhagic infarction. J Stroke Cerebrovasc Dis. 2022 Apr;31(4):106395.
Powers, William J. “Strokelore: Antithrombotic therapy and hemorrhagic infarction.” J Stroke Cerebrovasc Dis, vol. 31, no. 4, Apr. 2022, p. 106395. Pubmed, doi:10.1016/j.jstrokecerebrovasdis.2022.106395.
Powers WJ. Strokelore: Antithrombotic therapy and hemorrhagic infarction. J Stroke Cerebrovasc Dis. 2022 Apr;31(4):106395.
Published In
J Stroke Cerebrovasc Dis
DOI
EISSN
1532-8511
Publication Date
April 2022
Volume
31
Issue
4
Start / End Page
106395
Location
United States
Related Subject Headings
- Stroke
- Platelet Aggregation Inhibitors
- Neurology & Neurosurgery
- Infarction
- Humans
- Fibrinolytic Agents
- Brain Ischemia
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences